Validation of three coding algorithms to identify patients with end-stage liver disease in an administrative database

Pharmacoepidemiology and Drug Safety

Volumn 21, Issue 7, 2012, Pages 765-769

  Goldberg, D ^a   Lewis, J D ^a   Halpern, S D ^a   Weiner, Mark ^a   Lo Re III, Vincent ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Cirrhosis; End stage liver disease; Hepatic decompensation; ICD 9 CM code; Pharmacoepidemiology; Validation

Indexed keywords

ARTICLE; CHRONIC LIVER DISEASE; DATA BASE; DECOMPENSATED LIVER CIRRHOSIS; ELECTRONIC MEDICAL RECORD; END STAGE LIVER DISEASE; HUMAN; ICD-9-CM; LIVER CIRRHOSIS; MAJOR CLINICAL STUDY; PATIENT IDENTIFICATION; PREDICTIVE VALUE; PRIORITY JOURNAL;

EID: 84863557612     PISSN: 10538569     EISSN: 10991557     Source Type: Journal    
DOI: 10.1002/pds.3290     Document Type: Article

References (13)

1. Kramer JR, Davila JA, Miller ED, Richardson P, Giordano TP, El-Serag HB. The validity of viral hepatitis and chronic liver disease diagnoses in Veterans Affairs administrative databases. Aliment Pharmacol Ther 2008; 27(3): 274-282. Epub 2007/11/13.
2. Lo Re V, 3rd, Lim JK, Goetz MB, et al. Validity of diagnostic codes and liver-related laboratory abnormalities to identify hepatic decompensation events in the Veterans Aging Cohort Study. Pharmacoepidemiol Drug Saf 2011; 20(7): 689-699. Epub 2011/06/01.
3. Arvaniti V, D'Amico G, Fede G, et al. Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis. Gastroenterology 2010; 139(4): 1246-1256, 56 e1-5. Epub 2010/06/19.
4. Garcia-Tsao G, Friedman S, Iredale J, Pinzani M. Now there are many (stages) where before there was one: In search of a pathophysiological classification of cirrhosis. Hepatology 2010; 51(4): 1445-1449. Epub 2010/01/16.
5. Kudo M, Zheng RQ, Kim SR, et al. Diagnostic accuracy of imaging for liver cirrhosis compared to histologically proven liver cirrhosis. A multicenter collaborative study. Intervirology 2008; 51(Suppl 1): 17-26. Epub 2008/06/27.
6. Mathurin P, Moreno C, Samuel D, et al. Early liver transplantation for severe alcoholic hepatitis. N Engl J Med 2011; 365(19): 1790-1800. Epub 2011/11/11.
7. Murray KF, Carithers RL, Jr. AASLD practice guidelines: Evaluation of the patient for liver transplantation. Hepatology 2005; 41(6): 1407-1432. Epub 2005/05/10.
8. Bell BP, Manos MM, Zaman A, et al. The epidemiology of newly diagnosed chronic liver disease in gastroenterology practices in the United States: results from population-based surveillance. Am J Gastroenterol 2008; 103(11): 2727-2736; quiz 37. Epub 2008/08/08.
9. Armstrong GL, Wasley A, Simard EP, McQuillan GM, Kuhnert WL, Alter MJ. The prevalence of hepatitis C virus infection in the United States, 1999 through 2002. Ann Intern Med 2006; 144(10): 705-714.
10. Goldstein ST, Zhou F, Hadler SC, Bell BP, Mast EE, Margolis HS. A mathematical model to estimate global hepatitis B disease burden and vaccination impact. Int J Epidemiol 2005; 34(6): 1329-1339. Epub 2005/10/27.
11. Kim WR, Brown RS, Jr., Terrault NA, El-Serag H. Burden of liver disease in the United States: summary of a workshop. Hepatology 2002; 36(1): 227-242. Epub 2002/06/27.
12. Sorrell MF, Belongia EA, Costa J, et al. National Institutes of Health Consensus Development Conference Statement: management of hepatitis B. Ann Intern Med 2009; 150(2): 104-110. Epub 2009/01/07.
13. WHO. Hepatitis C-global prevalence (update). Wkly Epidemiol Rec 2000; 75: 18-19.